Gene symbol and protein | Gene Location | All allelic disease phenotypes - locus/disease symbols |
ABCC9 ATP-binding cassette, sub-family C (member 9)   | 16p13.1 |  | Cardiomyopathy, dilated, 1O -CMD1O
|
|
ABCD1 ATP-binding cassette, sub-family D (ALD), member 1   | Xq28 |  | Adrenoleukodystrophy -ALD
|  | Adrenomyeloneuropathy -ALD
|
|
ABHD5 abhydrolase domain containing 5   | 3p25.3-p24.3 |  | Chanarin-Dorfman syndrome -CDS
|
|
ACADVL acyl-Coenzyme A dehydrogenase, very long chain   | 17p13 |  | Acyl-CoA dehydrogenase (very long chain) deficiency -VLCAD
|
|
ACTA1 alpha actin, skeletal muscle   | 1q42.13-q42.2 |  | Myopathy, actin -ASMA
|  | Congenital myopathy with excess of thin myofilaments, included -ASMA
|  | Myopathy, nemaline -NEM1
|  | myopathy, congenital, with fiber-type disproportion -CFTD
|  | Nemaline myopathy 2, autosomal recessive -NEM2
|
|
ACTC1 actin, alpha, cardiac muscle precursor   | 15q11-q14 |  | Cardiomyopathy, dilated, 1R -CMD1R
|  | Cardiomyopathy, familial hypertrophic -CMH1
|  | Asymmetric septal hypertrophy -ASH
|
|
ACTN2 actinin alpha2  | 1q42-q43 |  | dilated cardiomyopathy, 1aa -CMD1AA
|
|
ACVR1 activin A receptor, type II-like kinase 2   | 2q23-q24 |  | Fibrodysplasia ossificans progressiva -FOP
|
|
AGL Amylo-1,6-glucosidase, 4-alpha-glucanotransferase   | 1p21 |  | Glycogen storage disease type IIIa -GSD IIIa
|  | Glycogen storage disease type IIIb -GSD IIIb
|  | Glycogen storage disease type IIIc -GSD IIIc
|  | Glycogen storage disease type IIId -GSD IIId
|
|
ALDH3A2 aldehyde dehydrogenase 3A2   | 17p11.2 |  | Sjogren-Larsson syndrome -SLS
|  | Aldehyde dehydrogenase, family 3, subfamily A, member 2 -ALDH3A2
|  | Fatty aldehyde dehydrogenase -FALDH
|
|
ALS2 | 2q33.2 |  | Amyotrophic lateral sclerosis, juvenile -ALS2
|  | Primary lateral sclerosis, juvenile -PLSJ
|  | Spastic paralysis, infantile onset ascending -IAHSP
|
|
ANG | 14q11.2 |  | amyotrophic lateral sclerosis 9 -ALS9
|
|
ANK2 | 4q25-q27 |  | Long QT syndrome-4 -LQT4
|
|
ANKRD1 ankyrin repeat domain 1 (cardiac muscle)   | 10q23.33 | |
ANO5 anoctamin 5  | 11p14.3 |  | Muscular dystrophy, limb-girdle, type 2L -LGMD2L
|
|
APOA1 apolipoprotein A-I precursor   | 11q23-q24 |  | Amyloidosis, 3 or more types -APOA1
|  | ApoA-I and apoC-III deficiency, combined -APOA1
|  | Corneal clouding, autosomal recessive -APOA1
|  | Hypertriglyceridemia, one form -APOA1
|  | Hypoalphalipoproteinemia -APOA1
|
|
APTX | 9p13.3 |  | Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia -EAOH
|
|
AR | Xq11.2-q12 |  | Prostate cancer -AR
|  | Androgen insensitivity -AIS
|  | Spinal and bulbar muscular atrophy of Kennedy -SBMA
|  | Breast cancer, male, with Reifenstein syndrome -DHTR
|  | Perineal hypospadias -DHTR
|
|
ARHGEF10 Rho guanine nucleotide exchange factor 10   | 8p23 |  | Slowed nerve conduction velocity, autosomal dominant -NCV
|
|
ATM ataxia telangiectasia mutated   | 11q22.3 |  | ataxia telangiectasia -AT
|
|
ATP2A1 ATPase, Ca++ transporting, fast twitch 1   | 16p12.1 |  | Brody myopathy -ATP2A1
|
|
ATXN1 | 6p23 |  | Olivopontocerebellar atrophy I -OPCA1
|  | Spinocerebellar ataxia 1 -SCA1
|
|
ATXN10 | 22q13.31 |  | Spinocerebellar ataxia 10 -SCA10
|
|
ATXN2 | 12q24.1 |  | Spinocerebellar ataxia 2 -SCA2
|  | Olivopontocerebellar atrophy II -OPCA
|
|
ATXN3 | 14q24.3-q32.2 |  | Machado-Joseph disease -MJD
|  | Spinocerebellar ataxia 3 -SCA3
|
|
ATXN7 | 3p21.1-p12 |  | Spinocerebellar ataxia 7 -SCA7
|  | Olivopontocerebellar atrophy III -OPCA3
|
|
ATXN8OS | 13q21 |  | Spinocerebellar ataxia 8 -SCA8
|
|